Gemstone Biotherapeutics

company

About

Gemstone Biotherapeutics is a pre-clinical research and development initiative.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
3D Technology,Alternative Medicine,Biotechnology,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Gemstone Biotherapeutics is a pre-clinical research and development initiative based in Baltimore, Maryland. Gemstone is dedicated to the field of regenerative medicine and specializes in developing improved methods for advanced wound healing and tissue vascularization using licensed technology from Johns Hopkins University. Their core technologies include innovative polymeric hydrogels and stem cell engineering methodologies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$225K
Gemstone Biotherapeutics has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on Jul 3, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 3, 2018 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Gemstone Biotherapeutics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant